Humira (AbbVie Inc.)
Welcome to the PulseAid listing for the Humira drug offered from AbbVie Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | AbbVie Inc. |
| NON-PROPRIETARY NAME: | Adalimumab |
| SUBSTANCE NAME: | |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | |
| DOSAGE FORM: | KIT |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2016-10-17 |
| END MARKETING DATE: | 0000-00-00 |
Humira HUMAN PRESCRIPTION DRUG Details:
| Item Description | Humira from AbbVie Inc. |
| LABELER NAME: | AbbVie Inc. |
| DEA SCHEDULE: | |
| ACTIVE STRENGTH: | () |
| START MARKETING DATE: | 2016-10-17 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0074-0067_45805ad6-c43a-4b70-7d7c-d476cf5116b9 |
| PRODUCT NDC: | 0074-0067 |
| APPLICATION NUMBER: | BLA125057 |